ecancermedicalscience

Policy

The Repurposing Drugs in Oncology (ReDO) Project

10 Jul 2014
Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P Sukhatme

The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outlines some of the characteristics used in the selection of drug candidates by this project. Challenges in moving candidate drugs into clinical trial and subsequent practice are also discussed.

Article metrics: 11705 views
3077
8628

Related Articles

Marco Cattaneo, Lina Badimon, Giancarlo Agnelli, Andrew T Chan, Angel Lanas, Bianca Rocca, Peter Rothwell, Paola Patrignani, Ruth Langley, Gemma Vilahur, Francesco Cosentino
Valentina Pinzi, Valeria Landoni, Federica Catani, Roberta Lazzari, Barbara Alicja Jereczek-Fossa, Roberto Orecchia
Georges El Hachem, Francisco Oliveira Rocha, Thierry Pepersack, Youssef Jounblat, Annie Drowart, Lissandra Dal Lago
Fausto Maffini, Daniele Lorenzini, Daniela Lepanto, Elvio De Fiori, Caterina Fumagalli, Alessandra Rappa, Marta Tagliabue, Massimo Barberis